Stavros Giannakopoulos

Stavros Giannakopoulos is a seasoned scientist with extensive experience in drug discovery and molecular biology. Currently serving as Principal Scientist and Project Leader at Silence Therapeutics plc since February 2020, Stavros has previously held significant roles at Vertex Pharmaceuticals as Research Fellow I and Associate Director, and at BioMarin Nederland B.V. as Senior Scientist I. Additional experience includes positions as Scientific Study Manager and Scientist at Prosensa Therapeutics B.V. and post-doctoral fellowships at Erasmus MC and NYU Medical Center. Stavros earned a PhD in Molecular Biology from New York University and a BSc in Biology from Ethnikon kai Kapodistriakon Panepistimion Athinon.